Company Completing 3-year Prospective, Multicenter, Clinical Study
AI Integrated Urine Based Liquid Biopsy with High Sensitivity and Specificity
New study to Include 10 Additional Cancer Types
DELRAY...
HONG KONG, June 29, 2023 - (ACN Newswire) - A biotechnology company in China - Laekna, Inc. (stock code: 2105.HK), today listed on the Main Board of The...
High-intensity focused ultrasound (HIFU) is an early-stage, non-invasive thermal therapy used to treat a variety of medical conditions, including neurological disorders...
Top Stories This Week Sam Bankman-Fried: ‘I didn’t steal funds, and I certainly didn’t stash billions away.’ In a “pre-mortem overview” of FTX’s bankruptcy,...
Data published in Clinical and Translational Radiation Oncology Peer-reviewed clinical case study reported preliminary data on the first-in-human administration of NBTXR3 for the treatment of pancreatic cancer not eligible for surgery, demonstrating feasibility with no treatment-related toxicity Case study provides the first demonstration of local endoscopic delivery of NBTXR3 to a deep visceral tumor, and […]
